About

About Shionogi About Shionogi Inc. Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., a Japanese research-driven pharmaceutical company. Since 1878, we have been harnessing the full potential of science to address global health challenges. Over the past six decades, we have discovered several novel antibiotics and medications for HIV and influenza. Today, we're building on our scientific legacy by providing an antibiotic for difficult-to-treat Gram-negative bacterial infections and developing an investigational oral antiviral for COVID-19. Beyond infectious Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., an over 145-year-old global pharmaceutical company with headquarters in Osaka, Japan. In the U.S., Shionogi Inc. leverages our science-based heritage to develop and commercialize pharmaceutical products to treat unmet medical needs in our core areas of infectious diseases and pain, as well as other areas of high medical need. Shionogi strives constantly to supply the best possible medicine to protect the health and wellbeing of the patients we serve. Shionogi, Inc. is a subsidiary of Shionogi & Co., Ltd., a 145-year-old global pharmaceutical company headquartered in Osaka, Japan. Shionogi Inc. leverages our science-based heritage to develop & commercialize pharmaceutical products to treat unmet medical needs in our core area of infectious diseases and other areas of high medical need.